Vaxxinity, Inc. (VAXX)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $1.27 million as of March 9, 2026. Its market cap has increased by 2,400.00% in one year.
Market Cap
1.27M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 1.27M, a decrease of -99.94%. That is a compound annual growth rate of -82.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.27M | 3,233.36% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 1.20M |
| Entia Biosciences | 1.37M |
| Neon Bloom | 1.40M |
| International Stem Cell | 1.13M |
| Evofem Biosciences | 1.13M |
| Halberd | 1.09M |
| inTerra Resources | 1.49M |
| Eastgate Biotech | 1.06M |